Top Anti Cancer Imported Medicine Drugs in India - Pharma Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Bexlutry (Lutetium Lu 177 dotatate) Medicine in India

Bexlutry (Lutetium Lu 177 dotatate)

Medicine name : Bexlutry

Generic name : Lutetium Lu 177 dotatate

Manufactured By : Curium

Indications : Treatment of adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors.

Medicine Description : A targeted radioligand therapy for adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Bexlutry (Lutetium Lu 177 dotatate) is a radiolabeled somatostatin analog that binds to somatostatin receptors expressed on neuroendocrine tumor cells and delivers targeted radiation to help destroy cancer cells. It is used to treat eligible adults with foregut, midgut, and hindgut neuroendocrine tumors.

Product Introduction

Bexlutry (Lutetium Lu 177 Dotatate) is a targeted radioligand therapy used to treat adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). It belongs to a group of medicines called radiopharmaceuticals and works by binding to somatostatin receptors on cancer cells and delivering targeted radiation through the radioactive isotope Lutetium-177. This radiation damages the cancer cells and helps slow tumor growth and disease progression.

Bexlutry (Lutetium Lu 177 Dotatate) is administered as an intravenous infusion by healthcare professionals experienced in radiopharmaceutical treatments. The treatment schedule and dosage are determined by your doctor based on your condition and response to therapy. Patients may receive amino acid solutions during treatment to help protect the kidneys from radiation exposure. Regular blood tests and kidney and liver function assessments may be required to monitor treatment response and identify possible complications. Follow your doctor's instructions carefully and attend all scheduled appointments.

Common side effects of Bexlutry (Lutetium Lu 177 Dotatate) may include nausea, vomiting, fatigue, decreased appetite, abdominal pain, diarrhea, constipation, and hair loss. It may also cause serious complications such as low blood cell counts, kidney problems, liver toxicity, hormonal disturbances, and, rarely, myelodysplastic syndrome or acute leukemia. Inform your doctor promptly if you experience unusual bleeding, persistent fever, severe fatigue, reduced urine output, or other concerning symptoms. Before starting treatment, tell your doctor about your medical history and all medicines, vitamins, and supplements you are taking. Your healthcare team will advise you on radiation-safety precautions and any necessary pregnancy-prevention measures during and after treatment.

Uses Of Bexlutry (Lutetium Lu 177 dotatate)

Treatment of Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Benefits Of Bexlutry

Bexlutry (Lutetium Lu 177 Dotatate) is used to treat adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). It binds to somatostatin receptors on cancer cells and delivers targeted radiation, helping damage tumor cells, slow cancer growth, and control disease progression.

Side Effects Of Bexlutry (Lutetium Lu 177 dotatate)

Some side effects of Bexlutry (Lutetium Lu 177 Dotatate) may improve as your body adjusts to the treatment. Consult your doctor if they persist, become severe, or cause concern.

Common Side Effects of Bexlutry (Lutetium Lu 177 dotatate)

  • Nausea
  • Vomiting
  • Fatigue
  • Decreased appetite
  • Abdominal pain
  • Diarrhea
  • Constipation
  • Hair loss
  • Headache
  • Dizziness
How To Use Bexlutry

Bexlutry (Lutetium Lu 177 Dotatate) is administered as an intravenous infusion by trained healthcare professionals in a specialised medical facility. The recommended dose and treatment schedule are determined by your doctor based on your condition. An amino acid solution is given alongside treatment to help protect the kidneys from radiation exposure. Regular blood tests and kidney and liver function monitoring may be required. Follow all radiation-safety instructions provided by your healthcare team.

How Bexlutry (Lutetium Lu 177 dotatate) Works

Bexlutry (Lutetium Lu 177 Dotatate) is administered as an intravenous infusion by trained healthcare professionals in a specialised medical facility. The recommended dose and treatment schedule are determined by your doctor based on your condition. An amino acid solution is given alongside treatment to help protect the kidneys from radiation exposure. Regular blood tests and kidney and liver function monitoring may be required. Follow all radiation-safety instructions provided by your healthcare team.

Storage Conditions
  • Store Bexlutry in its original, radiation-shielded container.
  • Maintain the storage temperature specified on the product label.
  • Protect the injection from direct sunlight and unnecessary exposure to heat
  • Store and handle the product only in an authorised radiopharmacy or specialised medical facility, following radiation-safety regulations
Safety Advice

AlcoholAlcohol CONSULT YOUR DOCTOR

Avoid excessive alcohol consumption during treatment with Bexlutry (Lutetium Lu 177 Dotatate), as it may worsen nausea, dizziness, or fatigue. Consult your doctor before consuming alcohol.

PregnancyPregnancy CONSULT YOUR DOCTOR

Bexlutry may cause harm to an unborn baby. Pregnancy should be avoided during treatment and for the recommended period after the final dose. Women who can become pregnant should use effective contraception as advised by their doctor.

BreastfeedingBreastfeeding CONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment with Bexlutry (Lutetium Lu 177 Dotatate). Consult your doctor about when it may be safe to resume breastfeeding.

DrivingDriving CONSULT YOUR DOCTOR

Bexlutry may cause fatigue, dizziness, or weakness, which can affect concentration and alertness. Avoid driving or operating machinery if you experience these effects.

KidneyKidney CAUTION

Bexlutry may cause kidney toxicity. Inform your doctor if you have kidney problems before starting treatment. Kidney function should be monitored regularly, and protective amino acid solutions are administered during treatment.

LiverLiver CAUTION

Bexlutry may affect liver function. Inform your doctor if you have liver disease before starting treatment. Regular liver function tests may be required to monitor for possible complications.

Quick Tips
  • Receive Bexlutry only under the supervision of trained healthcare professionals.
  • Attend all scheduled treatment sessions and follow your doctor's instructions.
  • Drink adequate fluids as advised by your healthcare team to support kidney function.
  • Attend regular blood tests and kidney and liver function check-ups.
  • Follow all radiation-safety precautions provided by your healthcare team after treatment.
  • Read More About - Bexlutry (Lutetium Lu 177 dotatate) from Pharma Five.
About Pharma Five

Pharma Five assists patients in accessing Bexlutry (Lutetium Lu 177 Dotatate) through small-quantity import facilitation for personal medical use, subject to applicable regulations. Patients may be required to provide the prescribed application documents, including Form 12A and a valid prescription from a Registered Medical Practitioner (RMP), as applicable.

With over two decades of pharmaceutical industry experience, Pharma Five provides professional pharmaceutical consultancy and import facilitation services. The team supports patients seeking Bexlutry (Lutetium Lu 177 Dotatate) and other specialised medicines by helping them navigate documentation requirements and applicable import procedures. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

References
  1. https://go.drugbank.com/drugs/DB13985
  2. https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dotatate
  3. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7642094-9ec6-4927-8582-bbe60e5e74cc
  4. https://www.curiumpharma.com/fda-approval-bexlutry/
Faq

General Question

Bexlutry (Lutetium Lu 177 Dotatate) is a prescription radioligand therapy used to treat adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). It delivers targeted radiation to tumor cells to help control cancer growth.

Bexlutry binds to somatostatin receptors on neuroendocrine tumor cells. Its radioactive component, Lutetium-177, releases radiation that damages cancer-cell DNA and helps slow tumor progression.

Bexlutry is prescribed for adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors. A specialist determines whether the treatment is suitable based on the tumor characteristics and the patient’s condition.

Bexlutry is given as an intravenous infusion by trained healthcare professionals in a specialised medical facility. An amino acid solution is also administered to help protect the kidneys during treatment.

Common side effects of Bexlutry may include nausea, vomiting, fatigue, decreased appetite, abdominal pain, diarrhea, constipation, hair loss, headache, and dizziness.

Serious side effects may include low blood cell counts, kidney toxicity, liver problems, hormonal disturbances, and bone marrow disorders such as myelodysplastic syndrome or acute leukemia. Contact your doctor if you experience unusual bleeding, persistent fever, or severe weakness.

The duration of Bexlutry treatment depends on your diagnosis, treatment response, and tolerance. Your specialist determines the treatment schedule and number of doses.

Avoid excessive alcohol consumption during Bexlutry treatment and consult your doctor before drinking alcohol, particularly if you experience nausea, dizziness, or fatigue.

Bexlutry may harm an unborn baby. Pregnancy should be avoided during treatment and for the recommended period afterward. Discuss effective contraception and pregnancy planning with your doctor.

Bexlutry may interact with other treatments or medicines and can affect blood counts and organ function. Inform your healthcare team about all prescription medicines, supplements, and ongoing cancer treatments.

Bexlutry is administered by healthcare professionals, so patients do not need to manage missed doses themselves. Contact your treatment team if an appointment is missed or delayed.

Bexlutry is administered intravenously and is not taken with food. Follow your healthcare team’s instructions regarding eating and drinking before and after treatment.

Inform your doctor about existing kidney or liver problems, previous cancer treatments, and all medicines you take. Attend scheduled blood tests and follow radiation-safety precautions after treatment.

Bexlutry should be stored in its original radiation-shielded packaging under the storage conditions specified by the manufacturer. It must be handled and stored by authorised healthcare or radiopharmacy professionals.

Bexlutry is a specialised prescription radiopharmaceutical and should be obtained through authorised pharmaceutical suppliers or medical facilities. Pharma Five may assist patients with access and applicable personal import procedures. Pharma Five assists in its procurement.

Timely Service
Doorstep Delivery
Hassle-Free Process
100% Genuine Sources